You are here

SER-109

FDA approves first oral microbiome therapy Vowst

Fierce Pharma

Thu, 04/27/23 - 11:53 am

Seres Therapeutics

Seres one step closer to bringing first oral microbiome therapy to market as FDA mulls approval

Fierce Biotech

Wed, 10/26/22 - 10:51 am

Seres Therapeutics

Seres, Vera Notch Weekend Wins in C.Diff, Lupus Trials

BioSpace

Mon, 05/23/22 - 10:22 am

Seres Therapeutics

clinical trials

Vera Therapeutics

Battered and bruised Seres Therapeutics see shares skyrocket on phase 3 win

Fierce Biotech

Tue, 08/11/20 - 11:35 am

Seres Therapeutics

Seres Therapeutics stock rockets nearly fourfold after positive Phase 3 data on treatment for colon infections

Marketwatch

Mon, 08/10/20 - 11:03 pm

Seres Therapeutics

clinical trials

Seres doubles down on a microbiome do-over as the FDA clears a make-or-break study

Endpoints

Thu, 03/16/17 - 09:49 am

Seres Therapeutics

clinical trials